Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration

Administration of high doses of methamphetamine (METH) causes persistent dopaminergic deficits in both nonhuman preclinical models and METH-dependent persons. Noteworthy, adolescent (i.e., postnatal day (PND) 40) rats are less susceptible to this damage than young adult (PND90) rats. In addition, bi...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: McFadden, Lisa M, Hoonakker, Amanda J, Vieira-Brock, Paula L, Stout, Kristen A, Sawada, Nicole M, Ellis, Jonathan D, Allen, Scott C, Walters, Elliot T, Nielsen, Shannon M, Gibb, James W, Alburges, Mario E, Wilkins, Diana G, Hanson, Glen R, Fleckenstein, Annette E
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2011
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908924/
https://ncbi.nlm.nih.gov/pubmed/21190217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/syn.20902
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια